Brett Schroeder, Constance Yuan, Hao-Wei Wang, Chirayu Mohindroo, Hong Zhou, Mark Raffeld, Liqiang Xi, Evgeny Arons, Julie Feurtado, Lacey James-Echenique, Katherine R. Calvo, Irina Maric, Robert J. Kreitman. "Phase 2 trial of rituximab with either pentostatin or bendamustine for multiply relapsed or refractory hairy cell leukemia." Blood, 2026. doi:10.1182/blood.2025031243